Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
BIOS Fund III, LP - 05 May 2025 SCHEDULE 13G Report for OPUS GENETICS, INC. Common Stock, $0.0001 par value per share (RNTX)
- Filing manager
- BIOS Fund III, LP
- Reporting owner
- BIOS EQUITY PARTNERS III, LP
- Beneficially owned shares
- 3,683,429 shares
- Large-stake signal
-
Ownership
6.2%Beneficial ownership of this reported class.
Shares
3,683,429 sharesShares beneficially owned as disclosed.
Event date
05 May 2025Date tied to the ownership event or amendment.
Accepted by SEC
11 Aug 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 6.2%
- Symbol
- RNTX
- Shares outstanding
- 59,410,145 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 11 Aug 2025, 18:56:36 UTC
- Event date
- 05 May 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
BIOS Fund III, LP disclosed 6.2% ownership in OPUS GENETICS, INC. Common Stock, $0.0001 par value per share (RNTX) on 05 May 2025.
Key facts
- BIOS Fund III, LP filed SCHEDULE 13G for OPUS GENETICS, INC. Common Stock, $0.0001 par value per share (RNTX).
- Disclosed ownership: 6.2%.
- Date of event: 05 May 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Aug 2025, 18:56.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (10)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOS FUND III, LP | 0.7% | 430,665 | 0 | 430,665 | John Fucci | Attorney-in-Fact | |
| BIOS FUND III QP, LP | 4.7% | 2,801,953 | 0 | 2,801,953 | John Fucci | Attorney-in-Fact | |
| BIOS FUND III NT, LP | 0.8% | 450,811 | 0 | 450,811 | John Fucci | Attorney-in-Fact | |
| BIOS EQUITY PARTNERS III, LP | 6.2% | 3,683,429 | 0 | 3,683,429 | John Fucci | Attorney-in-Fact | |
| CAVU MANAGEMENT, LP | 6.2% | 3,683,429 | 0 | 3,683,429 | John Fucci | Attorney-in-Fact | |
| BIOS CAPITAL MANAGEMENT, LP | 6.2% | 3,683,429 | 0 | 3,683,429 | John Fucci | Attorney-in-Fact | |
| CAVU ADVISORS, LLC | 6.2% | 3,683,429 | 0 | 3,683,429 | John Fucci | Attorney-in-Fact | |
| BIOS ADVISORS GP, LLC | 6.2% | 3,683,429 | 0 | 3,683,429 | John Fucci | Attorney-in-Fact | |
| LESLIE WAYNE KREIS, JR. | 6.2% | 3,683,429 | 0 | 3,683,429 | John Fucci | Attorney-in-Fact | |
| AARON GLENN LOUIS FLETCHER | 6.2% | 3,683,429 | 0 | 3,683,429 | John Fucci | Attorney-in-Fact |
CIK / CUSIP context first